Hobo Seiji, Niwa Hidekazu, Anzai Toru, Jones James H
Epizootic Research Center, Equine Research Institute, Japan Racing Association, 1400-4 Shiba, Shimotsuke, Tochigi 329-0412, Japan.
Department of Surgical and Radiological Science, Giannini Equine Athletic Performance Laboratory, School of Veterinary Medicine, University of California, Davis, CA 95616, U.S.A.
J Equine Sci. 2010;21(3):33-7. doi: 10.1294/jes.21.33. Epub 2010 Oct 22.
In this study, to evaluate the influence of strangles vaccination on serological test results, we investigated the changes in strangles serum antibody levels in horses after vaccination and subsequent intranasal challenge with S. equi. The horses were vaccinated for strangles with either a component vaccine (Group C) or a live vaccine (Group L). We measured changes in strangles serum antibody levels weekly for 20 weeks after vaccinating horses twice for strangles over a 3-week interval, and for 7 weeks after intranasal challenge with S. equi in the same horses. Serum antibody responses to the proline-glutamic acid-proline-lysine (PEPK) antigen with five repetitions (PEPK-5R) were higher at all times (up to 2.4-fold) following vaccination in Group C than in Group L, and the value peaked at 2.9-fold above the initial value after the second vaccination in Group C horses. However, the value was lower than that in horses infected with S. equi, and it gradually decreased, reaching the initial (week 0) value by the 15th week. Serum antibody responses to PEPK-5R after challenge with S. equi increased in both groups of horses, but the value tended to be lower than that reported for unvaccinated horses. In addition, the average value in Group C was 2.6-fold higher than that of Group L. These results suggest the serum antibody responses of horses infected with S. equi varies according to the type of vaccine with which they have been vaccinated. Although the serological diagnostic test for strangles in which PEPK-5R is used as an antigen is effective for the investigation of serum antibodies to strangles in vaccinated horses, the present data suggest it is necessary to consider the vaccination history when interpreting the results.
在本研究中,为评估马腺疫疫苗接种对血清学检测结果的影响,我们调查了马匹接种疫苗后以及随后用马链球菌进行鼻腔攻毒后马腺疫血清抗体水平的变化。马匹分别接种了成分疫苗(C组)或活疫苗(L组)以预防马腺疫。我们在3周间隔内对马匹进行两次马腺疫疫苗接种后的20周内,以及对同一批马匹用马链球菌进行鼻腔攻毒后的7周内,每周测量马腺疫血清抗体水平的变化。在所有时间点,C组接种疫苗后对五重复脯氨酸-谷氨酸-脯氨酸-赖氨酸(PEPK)抗原(PEPK-5R)的血清抗体反应均高于L组(高达2.4倍),C组马匹在第二次接种后该值达到比初始值高2.9倍的峰值。然而,该值低于感染马链球菌的马匹,并且逐渐下降,到第15周时降至初始(第0周)值。两组马匹在用马链球菌攻毒后对PEPK-5R的血清抗体反应均增加,但该值往往低于未接种疫苗马匹的报告值。此外,C组的平均值比L组高2.6倍。这些结果表明,感染马链球菌的马匹的血清抗体反应因所接种疫苗的类型而异。虽然以PEPK-5R为抗原的马腺疫血清学诊断试验对检测接种疫苗马匹的马腺疫血清抗体有效,但目前的数据表明,在解释结果时需要考虑疫苗接种史。